<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0404511</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7473</journal-id>
<journal-id journal-id-type="nlm-ta">Science</journal-id>
<journal-id journal-id-type="iso-abbrev">Science</journal-id>
<journal-title-group>
<journal-title>Science (New York, N.Y.)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0036-8075</issn>
<issn pub-type="epub">1095-9203</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26966193</article-id>
<article-id pub-id-type="pmc">4901875</article-id>
<article-id pub-id-type="doi">10.1126/science.aaf2669</article-id>
<article-id pub-id-type="manuscript">NIHMS789589</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Autism-Associated SHANK3 Haploinsufficiency Causes I<sub>h</sub>-Channelopathy in Human Neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Danko</surname>
<given-names>Tamas</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Botelho</surname>
<given-names>Salome Calado</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patzke</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pak</surname>
<given-names>ChangHui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wernig</surname>
<given-names>Marius</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>SÃ¼dhof</surname>
<given-names>Thomas C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">#</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA
</aff>
<aff id="A2"><label>2</label>Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA
</aff>
<aff id="A3"><label>3</label>Department of Pathology, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA
</aff>
<aff id="A4"><label>4</label>Howard Hughes Medical Institute, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA
</aff>
<author-notes>
<fn id="FN1">
<label>*</label>
<p id="P1">Co-first authors</p>
</fn>
<corresp id="CR1"><label>#</label>Address for correspondence (<email>tcs1@stanford.edu</email>)
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>6</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>6</month>
<year>2016</year>
</pub-date>
<volume>352</volume>
<issue>6286</issue>
<fpage>aaf2669</fpage>
<lpage>aaf2669</lpage>
<!--elocation-id from pubmed: 10.1126/science.aaf2669-->
<abstract>
<p id="P2">Heterozygous <italic>SHANK3</italic> mutations are associated with idiopathic autism and Phelan-McDermid syndrome. SHANK3 is a ubiquitously expressed scaffolding protein that is enriched in postsynaptic excitatory synapses. Here we used engineered conditional mutations in human neurons to show that heterozygous and homozygous <italic>SHANK3</italic> mutations severely and specifically impair I<sub>h</sub>-channels. <italic>SHANK3</italic> mutations caused alterations in neuronal morphology and synaptic connectivity; chronic pharmacological blockage of I<sub>h</sub>-channels reproduced these phenotypes, suggesting they may be secondary to I<sub>h</sub>-channel impairment. Moreover, mouse <italic>Shank3</italic>-deficient neurons also exhibited severe decreases in I<sub>h</sub>-currents. SHANK3 protein interacted with hyperpolarization-activated cyclic nucleotide-gated channel proteins (HCN proteins) forming I<sub>h</sub>-channels, indicating that SHANK3 functions to organize HCN-channels. Our data suggest <italic>SHANK3</italic> mutations predispose to autism, at least partially, by inducing an I<sub>h</sub>-channelopathy that may be amenable to pharmacological intervention.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>